Herbalife Nutrition Ltd vs Jabil Inc — how do they compare? Herbalife Nutrition Ltd trades at $12.84 (market cap $1.34B), while Jabil Inc trades at $303.58 (market cap $31.35B). The key difference: Jabil Inc is far larger — about 23.4× Herbalife Nutrition Ltd's market cap, and Jabil Inc pays a 0.11% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Herbalife Nutrition Ltd for 43 Days and Jabil Inc for 23 Days on average.
| HLF | JBL | |
|---|---|---|
Market Cap | $1.34B | $31.35B |
Volume | 1,589,457 | 1,337,978 |
Sector | Consumer Staples | Technology |
52-Week High | $19.96 | $385.50 |
52-Week Low | $7.75 | $192.49 |
Typical Hold Time | 43 Days | 23 Days |
Enterprise Value | $3.18B | $33.63B |
Dividend Yield | — | 0.11% |
Signals from Pluang's Aura AI — not financial advice
HLF trades at $12.65, up 0.56% today, with a bullish technical signal from moving averages. The stock shows attractive valuation with a P/E of 8.22 and P/S of 0.26. Recent earnings were mixed, with a Q1 2026 beat but Q4 2025 and Q2 2026 misses. The company announced a $250 million share repurchase program and a CEO transition effective October 31, 2026. Cash flow trends show improvement, with 2026 projected net cash flow turning positive at $50 million.
The outlook is cautiously optimistic, supported by analyst consensus price target of $19.00 implying significant upside. Key opportunities include debt reduction progress and margin expansion plans. Risks include inconsistent earnings performance, high debt levels, and investor scrutiny following the CEO transition. The stock remains a value play if execution improves.
JBL trades at $301.76, up 0.76% today, with a bearish technical signal despite strong earnings beats in recent quarters. The stock shows robust fundamentals with revenue growth to $29.80B in 2025 and a high ROE of 74.11%, though net margins are thin at 2.9%. AI infrastructure demand is driving optimistic fiscal 2027 guidance, with a consensus analyst price target of $434.75 implying significant upside.
The outlook is positive due to accelerating AI-led growth and strong analyst support, but risks include market volatility post-earnings and high valuation multiples. Investment appeal hinges on execution of projected 24% revenue growth, while current technical weakness may present a buying opportunity for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →